Vaccine Scheduler
Spain and Sweden: Comparison of recommended vaccinations
| Spain | Sweden | |
|---|---|---|
| General recommendation | ||
| Recommendation for specific groups only | ||
| Catch-up (e.g. if previous doses missed) | ||
| Vaccination not funded by the National Health system | ||
| Mandatory vaccination | ||
| Birth | Weeks | Months | Years | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 2 | 3 | 4 | 5 | 6 | 11 | 12 | 15 | 18 | 3-4 | 5 | 6 | 8 | 10 | 12 | 13 | 14 | 15 | 16 | 18 | 45 | 60 | 64 | 65 | 74 | 75 | 79 | ≥ 80 | |||||
| Coronavirus disease (COVID-19)1 | COVID-192 | COVID-193 | |||||||||||||||||||||||||||||||
| COVID-194 | COVID-194 | COVID-195 | |||||||||||||||||||||||||||||||
| RSV | |||||||||||||||||||||||||||||||||
| RSV6 | RSV6 | ||||||||||||||||||||||||||||||||
| tuberculosis | |||||||||||||||||||||||||||||||||
| BCG7 | |||||||||||||||||||||||||||||||||
| rotavirus infection | ROTA8 | ||||||||||||||||||||||||||||||||
| ROTA | ROTA | ROTA9 | |||||||||||||||||||||||||||||||
| diphtheria | D | D | D | D | d | d10 | d11 | ||||||||||||||||||||||||||
| D | D | D | D | d12 | |||||||||||||||||||||||||||||
| tetanus | TT | TT | TT | TT | TT | TT10 | TT11 | ||||||||||||||||||||||||||
| TT | TT | TT | TT | TT12 | |||||||||||||||||||||||||||||
| pertussis | acP13 | acP13 | acP13 | acp14 | acp15 | ||||||||||||||||||||||||||||
| acP | acP | acP | acP | acp16 | acp17 | ||||||||||||||||||||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | |||||||||||||||||||||||||||||
| IPV | IPV | IPV | IPV | ||||||||||||||||||||||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | ||||||||||||||||||||||||||||||
| Hib | Hib | Hib | |||||||||||||||||||||||||||||||
| hepatitis B | HepB18 | HepB | HepB | HepB | HepB19 | ||||||||||||||||||||||||||||
| HepB20 | HepB | HepB | HepB21 | ||||||||||||||||||||||||||||||
| pneumococcal disease | PCV22 | PCV22 | PCV22 | PPSV23 / PCV+PPSV2323 | PPSV2324 | ||||||||||||||||||||||||||||
| PCV | PCV | PCV | PPSV2325 | ||||||||||||||||||||||||||||||
| meningococcal disease | MenB26 | MenB - MenC26 | MenB - MenC26 | MCV427 | MCV428 | ||||||||||||||||||||||||||||
| measles | MEAS | MEAS | MEAS29 | ||||||||||||||||||||||||||||||
| MEAS | MEAS30 | ||||||||||||||||||||||||||||||||
| mumps | MUMPS | MUMPS | MUMPS29 | ||||||||||||||||||||||||||||||
| MUMPS | MUMPS30 | ||||||||||||||||||||||||||||||||
| rubella | RUBE | RUBE | RUBE29 | ||||||||||||||||||||||||||||||
| RUBE | RUBE30 | ||||||||||||||||||||||||||||||||
| varicella | VAR | VAR | VAR31 | ||||||||||||||||||||||||||||||
| human papillomavirus infection | HPV (F/M)32 | HPV (F)33 | |||||||||||||||||||||||||||||||
| HPV (F/M)34 | |||||||||||||||||||||||||||||||||
| influenza | IIV35 | IIV36 | IIV37 | ||||||||||||||||||||||||||||||
| IIV338 | IIV3 | ||||||||||||||||||||||||||||||||
| herpes zoster | ZOS39 | ZOS40 | |||||||||||||||||||||||||||||||
Footnotes:
- 2023 recommendations https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/gripe_covid19/docs/RecomendacionesVacunacion_Gripe-Covid19.pdf
- COVID-19 vaccination in children under 5 years of age is recommended only for those with high risk conditions. https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/docs/Recomendaciones_vacunacion_Otono_Invierno_Covid.pdf
- https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/covid19/vacunasCOVID19_Profesionales.htm
- One dose offered in the period 1mar. 2023 - 29 feb. 2024 for specific risk groups from 18 years of age and individuals aged 65-79 years. interval of 6 months with a previous dose should be respected. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuella-utbrott/covid-19/vaccination-mot-covid-19/om-vaccinerna-mot-covid-19/nya-rekommendationer-for-vaccination-mot-covid-19/
- Two doses recommended in the period 1mar. 2023 - 29 feb. 2024 for individuals from 80 years and individuals residing in nursing homes. interval of 6 months between doses should be respected. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuella-utbrott/covid-19/vaccination-mot-covid-19/om-vaccinerna-mot-covid-19/nya-rekommendationer-for-vaccination-mot-covid-19/
- Vaccination is recommended for all people aged 75 and over. Vaccination is recommended for people aged 60 and over with certain diseases, diagnoses or conditions. More information available at: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/rekommendationer-for-vaccination/
- BCG vaccination is recommended for children up to 6 years of age who are at increased risk of being infected with TB according to the following criteria: (1) family origin from a country with increased or high TB incidence, (2) current TB in a close relative or household contact (3) for planned longer (more than three months) stay in a country or area with high TB prevalence, if the child comes into close contact with the local population. For more information, please visit: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vacciner-a-o/tuberkulos-tb/ and https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-for-preventiva-insatser-mot-tuberkulos-halsokontroll-smittsparning-och-vaccination/
- Additional information can be found at: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/docs/Rotavirus_Recomendaciones2024.pdf
- 3rd dose only indicated when a pentavalent rotavirus vaccine is used.
- Repeat for pregnant women starting from week 27 of the pregnancy (preferably at week 27 or 28)
- One dose at around 65 years of age if primary course completed. For additional information on catch-up vaccinations prior to 65 years of age, refer to specific recommendations available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/difteria-tetanos-tosferina.htm
- Given to 8-9 grade students. For adults above 18 years, dT Booster doses are recommended every 20 years (not funded by the National Health system)
- For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/difteria-tetanos-tosferina.htm
- For more detail on review and recommendation for pertussis vaccination in Spain, please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/docs/TosFerina.pdf
- Repeat for pregnant women starting from week 27 of the pregnancy (preferably at week 27 or 28).
- Given to 8-9 grade students.
- Vaccination offered to pregnant women after 16 weeks of pregnancy. More information available at: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/vaccinationer-till-vuxna/
- Babies born to a mother infected with hepatitis B will be offered a first dose at birth, 2, 4 and 11 months of age and HB immunoglobulin at birth (first 24 hours of life)
- Recommended for previously unvaccinated individuals up to 18 years of age (three doses at 0, 1 and 6 months)
- Babies born to a mother infected with hepatitis B will be offered a dose at birth simultaneously with HB immunoglobulin
- Vaccination against hepatitis B is recommended for children up to 18 years belonging to certain risk groups. For more information, please visit: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/r/rekommendationer-om-vaccination-mot-hepatit-b-/
- For recommendations in children and adults with high risk conditions Please refer to https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/riesgo/home.htm
- For recommendations in children and adults with high risk conditions, refer to: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/riesgo/home.htm
- Additional information https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/Vacunacion_poblacion_adulta.pdf
- https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/nationella-vaccinationsprogram/program-for-riskgrupper/
- Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/enf-meningococica.htm
- One dose at 12 years to individuals who have not received any doses of MCV4 since 10 years of age. Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/comoTrabajamos/enf-meningococica.htm
- The catch-up vaccination programme for individuals aged 13 to 18 years will be introduced gradually (more information available at: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/adolescentes-meningo/home.htm
- Two doses at 4 or more weeks interval recommended in individuals born in Spain since 1970 with no documented history of vaccination
- Given to 1-2 grade students
- 2 doses recommended at 4+ week-interval (preferably 8 weeks) to individuals with no documented history of disease and no documented prior vaccination (in the case of adults, vaccination is recommended if IgG serology for varicella is negative).
- Extension of HPV vaccination to boys aged 12, applicable since October 2022. Two-dose schedule (6 months intervals between doses).
- Previously unvaccinated girls. Three-dose schedule from 15 years of age.
- 9-valent. Gender-neutral (boys and girls) vaccination - School-based programme offered in fifth grade from August 2020.
- Additional information available at https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Recomendaciones_vacunacion_gripe_PoblacionInfantil.pdf
- Recommended for children and adults with high risk conditions. Additional information available: https://www.sanidad.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/docs/Recomendaciones_vacunacion_gripe.pdf
- Annual vaccination
- Funding varies by region
- Recommended for adults with certain risk conditions. Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. Additional information available: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf
- Two doses with a minimal interval of 2 months between doses. Vaccination with the inactivated herpes zoster subunit vaccine. Additional information available: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/programasDeVacunacion/docs/HerpesZoster_RecomendacionesVacunacion.pdf